» Articles » PMID: 20802517

DNA Copy Number Aberrations in Small-cell Lung Cancer Reveal Activation of the Focal Adhesion Pathway

Overview
Journal Oncogene
Date 2010 Aug 31
PMID 20802517
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Small-cell lung cancer (SCLC) is the most aggressive subtype of lung cancer in its clinical behavior, with a 5-year overall survival as low as 5%. Despite years of research in the field, molecular determinants of SCLC behavior are still poorly understood, and this deficiency has translated into an absence of specific diagnostics and targeted therapeutics. We hypothesized that tumor DNA copy number alterations would allow the identification of molecular pathways involved in SCLC progression. Array comparative genomic hybridization was performed on DNA extracted from 46 formalin-fixed paraffin-embedded SCLC tissue specimens. Genomic profiling of tumor and sex-matched control DNA allowed the identification of 70 regions of copy number gain and 55 regions of copy number loss. Using molecular pathway analysis, we found a strong enrichment in these regions of copy number alterations for 11 genes associated with the focal adhesion pathway. We verified these findings at the genomic, gene expression and protein level. Focal Adhesion Kinase (FAK), one of the central genes represented in this pathway, was commonly expressed in SCLC tumors and constitutively phosphorylated in SCLC cell lines. Those were poorly adherent to most substrates but not to laminin-322. Inhibition of FAK phosphorylation at Tyr(397) by a small-molecule inhibitor, PF-573,228, induced a dose-dependent decrease of adhesion and an increase of spreading in SCLC cell lines on laminin-322. Cells that tended to spread also showed a decrease in focal adhesions, as demonstrated by a decreased vinculin expression. These results support the concept that pathway analysis of genes in regions of copy number alterations may uncover molecular mechanisms of disease progression and demonstrate a new role of FAK and associated adhesion pathways in SCLC. Further investigations of FAK at the functional level may lead to a better understanding of SCLC progression and may have therapeutic implications.

Citing Articles

Promises of Protein Kinase Inhibitors in Recalcitrant Small-Cell Lung Cancer: Recent Scenario and Future Possibilities.

Tiwari A, Kumari B, Nandagopal S, Mishra A, Shukla K, Kumar A Cancers (Basel). 2024; 16(5).

PMID: 38473324 PMC: 10931009. DOI: 10.3390/cancers16050963.


Analysis of Breast Cancer Based on the Dysregulated Network.

Huo Y, Li X, Xu P, Bao Z, Liu W Front Genet. 2022; 13:856075.

PMID: 35242172 PMC: 8886234. DOI: 10.3389/fgene.2022.856075.


Clinical Significance and Potential Role of Overexpression in Hepatocellular Carcinoma: An Integrated Analysis Based on Multiple Databases.

Chen L, Lin Y, Liu G, Huang J, Wei W, Yang Z Front Genet. 2022; 12:804916.

PMID: 35096017 PMC: 8793693. DOI: 10.3389/fgene.2021.804916.


Antiangiogenesis Combined with Immunotherapy to Treat Advanced Small-Cell Carcinoma of the Esophagus Resistant to Chemotherapy: According to the Guidance of Next-Generation Sequencing.

Jiang M, Zhang X Onco Targets Ther. 2021; 14:1613-1621.

PMID: 33688208 PMC: 7936705. DOI: 10.2147/OTT.S293733.


Cellular Heterogeneity-Adjusted cLonal Methylation (CHALM) improves prediction of gene expression.

Xu J, Shi J, Cui X, Cui Y, Li J, Goel A Nat Commun. 2021; 12(1):400.

PMID: 33452255 PMC: 7811027. DOI: 10.1038/s41467-020-20492-7.


References
1.
Levin N, Brzoska P, Gupta N, Minna J, Gray J, Christman M . Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res. 1994; 54(19):5086-91. View

2.
Guan J, Trevithick J, Hynes R . Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul. 1991; 2(11):951-64. PMC: 361893. DOI: 10.1091/mbc.2.11.951. View

3.
Zhang B, Kirov S, Snoddy J . WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005; 33(Web Server issue):W741-8. PMC: 1160236. DOI: 10.1093/nar/gki475. View

4.
Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K . Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer. 2004; 46(1):11-9. DOI: 10.1016/j.lungcan.2004.03.006. View

5.
Webb D, Donais K, Whitmore L, Thomas S, Turner C, Parsons J . FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol. 2004; 6(2):154-61. DOI: 10.1038/ncb1094. View